News and Updates

Leading researchers gathered for the ATTD meeting, which featured more than 50 studies presented by Breakthrough T1D-funded researchers.

Breakthrough T1D advocate Natalie Stanback knows type 1 diabetes and knows how to get things done on Capitol Hill. She encourages more women to get involved in advocacy.

This year’s Advanced Technologies & Treatments for Diabetes (ATTD) meeting, which will be held on March 6-9, will have 50 Breakthrough T1D-funded presenters.

It’s Autoimmune Disease Awareness Month—but what are autoimmune diseases?

With an investment from the Breakthrough T1D T1D Fund, vTv Therapeutics will run a phase III clinical trial of cadisegliatin (TTP399), an adjunct therapy to insulin.

Leading researchers gathered in Long Beach, California, for the 16th annual meeting of the Network for Pancreatic Organ Donors with Diabetes (nPOD).

Leading scientists will gather for the annual meeting of the Network for Pancreatic Organ Donors with Diabetes (nPOD), held February 19-22 in California.

The Super Bowl MVPs for Type 1 Diabetes Awareness.

Breakthrough T1D funded 3 projects to address eating disorders + T1D and a study that presents the risks of T1D eating disorders and current barriers to safe treatment.

Learn about the many connected care options for managing type 1 diabetes (T1D), including smart insulin pens and pen caps.